At present, there is no discernible evidence of a cross-cutting or all-of-government strategy to increase the commercial dividends from the scientific capital we have accumulated in the biological sciences.
A 2017 report from Deloitte and BIOTECanada found 59 per cent of the companies said they were looking to government as their first source of future financing—the vast majority of such government funding comes through Innovation, Science, and Economic Development Canada, which is overseen by Navdeep Bains, pictured, as minister. The Hill Times photograph by Andrew Meade
TORONTO—Canada is rich in the scientific capital needed to make us a serious player in the transformative world of biotechnology.
People. Policy. Politics. This is an exclusive subscriber-only story.
CanCon Contributions & Quotas In a Digital Age As part of Heritage Canada’s review of Canadian content in a digital age, various parties are proposing changes to how digital services are regulated and taxed.
This campaign is not defined by any overarching issue, and has become ‘personal’ and ‘ugly’ between Prime Minister Justin Trudeau and Conservative Leader Andrew Scheer, says pollster and Ipsos president Darrell Bricker.